0000950138-20-000310.txt : 20200804 0000950138-20-000310.hdr.sgml : 20200804 20200804161518 ACCESSION NUMBER: 0000950138-20-000310 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200803 FILED AS OF DATE: 20200804 DATE AS OF CHANGE: 20200804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YOUNG TODD S. CENTRAL INDEX KEY: 0001682584 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 201073474 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825497352 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-08-03 0001739104 Elanco Animal Health Inc ELAN 0001682584 YOUNG TODD S. C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 0 1 0 0 See Remarks Common Stock 41513 D Common Stock 2020-08-03 4 P 0 2000 23.850 A 2000 I by J. G. Young IRA Common Stock 2020-08-03 4 P 0 5000 23.94 A 5000 I by IRA Tangible Equity Units 2020-08-03 4 P 0 1000 40.55 A Common Stock 1562 1000 I by IRA Each 5.00% Tangible Equity Unit (TEU) includes a prepaid stock purchase contract that will automatically settle on February 1, 2023 (unless settled early at the holder's discretion) for between 1.3021 and 1.5625 shares of Elanco's common stock (subject to adjustment in certain circumstances), based upon the applicable market value of Elanco's common stock prior to settlement. The Reporting Person may elect to settle the purchase contracts prior to February 1, 2023 at the minimum settlement rate of 1.3021 shares of Elanco's common stock. Additionally the purchase contracts may be settled early by the Reporting Person or Elanco under certain circumstances described in the purchase contract. Represents the maximum number of shares of Elanco's common stock initially issuable upon settlement of the purchase contract included in the TEUs based on the maximum settlement rate. Executive Vice President and Chief Financial Officer /s/ Darlene Quashie Henry, as Attorney-in-Fact for Todd S. Young 2020-08-04